TINA FERMANO: Open Payments
NPI 1407298748 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,298 in 205 payments from 25 companies in 2025. Trend: 2023 $1,652 · 2024 $2,300 · 2025 $2,298
Food & beverage: $2,298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $354 |
| Galderma Laboratories, L.P. | 11 | $262 |
| Arcutis Biotherapeutics, Inc. | 36 | $260 |
| Incyte Corporation | 52 | $247 |
| PFIZER INC. | 15 | $198 |
| Organon LLC | 12 | $109 |
| MAYNE PHARMA COMMERCIAL LLC | 13 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Janssen Biotech, Inc. | 4 | $77 |
Products named: SKYRIZI, Zoryve, OPZELURA, NEMLUVIO, CIBINQO, VTAMA, TREMFYA, RINVOQ.
Industry payments across NJ — which companies pay providers there.
